Open Access Open Access  Restricted Access Subscription or Fee Access

Domino Reaction for the Synthesis of Nitroolefin Heterocyclic Compound Via Thiazole Formation Followed by Claisen Rearrangement

N. Sivakumar, A. R.N. Vaishnavi, K. Mohankrishnan, A. Senthil

Abstract


The Baylis-Hillman adducts derived from nitroolefins have been conveniently transformed into Claisen rearrangement. These substances, which include benzothiazole moiety, are very biologically reactive substances. This novel nitro derivative of 2-((E)-2-nitro-3-phenylallyloxy)-3-ethoxybenzaldehyde was simply treated with mole percentage of 2-(2-(2-aminophenyl) disulfanyl) benzenamine in melt reactive condition. Hence this novel 2-(benzo[d]thiazol-2-yl)-6-ethoxy-4-((E)-2-nitro-3-phenylallyl)phenol core unit compounds was very intrusting and new opportunities for the preparation of closely related to the different [3,3] sigmatropic rearrangements related to the Claisen rearrangement molecule. In situ production of a monomer succeeded from an intramolecular [4 + 2] cycloaddition reaction have been shown to be a solid-state melt reaction (SSMR) for the manufacturing of tetracyclic chromenopyran pyrimidinedione frameworks employing Baylis-Hillman derivatives. High stereoselectivity and stereospecificity were used to create the tetracyclic frameworks without the need of a catalyst or solvent. The isolated yield is very good, and the pure product can be obtained without using column chromatography for purification.


Full Text:

PDF

References


Kita, M. Hirayama, Y. Yamagishi, K. Yoneda, K. Fujisawa, R. Kigoshi, H.J. Am. Chem. Soc. 2012; 134. 20314.

(a)Lee,Y.R. Hung T.V. Tetrahedron 2008;64. 7338. (b). Majumdar, K. C.; Taher, A.; Nandi, R.; Tetrahedron. 2012; 68.5693.

Arora, R.B. Mathur C. N. Brit. J. Pharmacol. 1963. 20. 29.

Sardari, S.Mori .Y. Horita K.Micetich R.G.; Nishibe S. Daneshtalab M. Bioorg. Med. Chem. 1999; 7. 1933.

Rajesh, P.M.Natvar P.J.J. Ad. Pharm Ed & Res, 2011; 1.52.

(a) Kashman, Y. Gustafson K.R. Fuller R.W. Cardellina J.H. McMahon J. et al Med. Chem. 1992;35.2735. (b) Lacy A. O’Kennedy, R. Curr. Pharm. Des. 2004;10.3797.

Appendino G. Cravotto G. Minassi A. Palmisano G. Eur. J. Org. Chem. 2001; 3711.

Appendino G. Cravotto G. Toma L. Annunziata R. Palmisano G.J. Org. Chem.1994;59.5556.

Mahmoud, A.A. Ahmed, A.A. Iinuma, M. Tanaka T. Phytochemistry 1998; 48. 543.

Mulholland D.A. Iourine S.E. Taylor D.A.H. Dean F.M. Phytochemistry 1998; 47. 1641.

Wang Y.Huang S,X.Xia P.Xia Y.Yang Z.Y. Kilgore N. Morris-Natschke S.L. Lee K.H. Bioorg. Med. Chem. Lett. 2007;17. 4316.

Elomri A. Michel, S. Skaltsounis A.L. Tillequin F. Koch, M. Pierre A. Guilbaud N. Leonce, S. Kraus L. Rolland Y. Atassi G. J. Med. Chem. 1996; 39.4762.

Magiatis P.M.S. Skaltsounis A.L. Tillequin F. Koch M. Pierre A. Atassi G. Chem. Pharm. Bull. 1999;47. 611.

(a) Ziegler F.E. Chem. ReV. 1988; 88. 1423. (b) Castro, A.M.M. Chem. ReV. 2004; 104.2939. (c). The Claisen Rearrangement Hiersemann M. Nubbemeyer U. Eds. Wiley-VCH: Weinheim

Germany. 2007.

Guz N.R. Lorenz P. Stermitz F.R. Tetrahedron Lett. 2001;42. 6491.


Refbacks

  • There are currently no refbacks.